C.R. Bard (NYSE:BCR) won’t be able to keep internal memos out of an upcoming bellwether trial over its recalled Avaulta pelvic mesh, a federal judge ruled last week.
Personal Injury
Robotic surgery complaints become FDA complaints
Bard bellwether mesh trial delayed until 2014
Pelvic mesh plaintiffs accuse Ethicon of destroying evidence
Plaintiffs in the multi-district pelvic mesh litigation against Johnson & Johnson‘s (NYSE:JNJ) Ethicon subsidiary want a federal judge to impose "severe sanctions" for the company’s alleged mishandling and destruction of 10s of thousands of documents in the case.
Did patients draw the short stick in $2.5B J&J metal hip settlement? | MassDevice.com On Call
MASSDEVICE ON CALL — When Johnson & Johnson (NYSE:JNJ) agreed to a $2.5 billion settlement to close some 8,000 cases over its metal-on-metal hip implants, about 1/3 of that money went to the lawyers and legal teams representing the cases.
Anti-Essure movement grows online as women slam Bayer’s implant | MassDevice.com On Call
MASSDEVICE ON CALL — The anti-Essure movement, launched by women who claim the permanent contraceptive implant left them with severe pain and injuries, doesn’t look likely to die down, having spawned Facebook support pages, Twitter campaigns and lots of media attention.
The movement has attached itself to the Twitter hashtag ‘#EssureRally’, through which women are calling on Bayer to recall the device, posting pictures of the ralliers in action and organizing real-world events, including street-corner picketing and conference calls with famed consumer advocate Erin Brockovich.